Home > Insider Trading > Filing (0001765581-22-000111)

Filing Details

Accession Number:: 0001765581-22-000111
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-08 16:55:04
Reporting Period:: 2022-09-06

Accepted Time:: 2022-09-08 16:55:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1232524	Jazz Pharmaceuticals Plc	JAZZ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1193210	C Bruce Cozadd	5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Disposition	2022-09-06	1,000	$155.10	353,311	No	4	S	Direct
Ordinary Shares	Acquisiton	2022-09-06	9,700	$59.13	363,011	No	4	M	Direct
Ordinary Shares	Disposition	2022-09-06	4,517	$152.41	358,494	No	4	S	Direct
Ordinary Shares	Disposition	2022-09-06	1,170	$153.13	357,324	No	4	S	Direct
Ordinary Shares	Disposition	2022-09-06	474	$154.31	356,850	No	4	S	Direct
Ordinary Shares	Disposition	2022-09-06	542	$155.22	356,308	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Non-Qualified Stock Option (right to buy)	Disposition	2022-09-06	9,700	$0.00	9,700	$59.13

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
62,905		2023-03-04	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $151.87 to $152.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $152.87 to $153.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $153.93 to $154.66. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $155.095 to $155.74. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
This non-qualified stock option is part of an option granted on March 5, 2013. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017.